Insmed Incorporated

符号: INSM

NASDAQ

26.58

USD

今天的市场价格

-5.0132
市盈率
0.5125
PEG比率
3.95B
MRK市值
0.00%
DIV收益率

Insmed Incorporated (INSM) 财务报表

Q: 什么是 Insmed Incorporated (INSM) 总资产是多少？

Insmed Incorporated (INSM) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Insmed Incorporated (INSM). 的默认数据。公司收入显示 44.723 M 的平均值，即 1.290 % 增长率。整个期间的平均毛利润为 31.714 M，即 1.228 %. 平均毛利率为 0.509 %. 公司去年的净收入增长率为 0.557 %，等于 -0.548 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Insmed Incorporated 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 -0.197. 在流动资产领域，INSM 的报告货币为929.063. 这些资产中的很大一部分，即 780.447 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.320%. 公司的长期投资虽然不是其重点，但以报告货币计算的6（如果有的话）为6。这表明与上一报告期相比，0.000% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 1193.352. 这一数字表明，0.022% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 -331.923. 这方面的年同比变化率为 -4.774%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为41.189，存货估值为 83.25，商誉估值为 136.11（如有. 无形资产总额（如果有）按 63.7 估值. 应付账款和短期债务分别为 65.39 和 10.64. 债务总额为1203.99，债务净额为 721.62. 其他流动负债为 214.99，加上总负债 1661.76. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000
balance-sheet.row.cash-and-short-term-investments	3482.85	780.4	1148.3	716.8	532.8	487.4	495.1	381.2	162.6	282.9	159.2	113.9	92.9	76.3	108	122.2	2.4	16.5	24.1	18.8	9.2	29.5	27.3	51.3	83.1	4.6
balance-sheet.row.short-term-investments	931.57	298.1	74.2	0	0	0	0	0	0	0	0	0	2.2	61.4	97.3	109.4	0.3	0	0	0	0	0	0	0	11.5	4.3
balance-sheet.row.net-receivables	138.24	41.2	29.7	24.4	16.6	19.2	5.5	0	0	0	0	0	0	0.8	0.5	2.3	0.1	0.3	0.2	0	0	0	0.2	3.5	0	0
balance-sheet.row.inventory	309.84	83.2	69.9	67	49.6	28.3	7	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	106.2	24.2	25.5	28.9	24	20.2	11.3	8.3	5.8	5.2	5.5	2.3	0.6	0.4	0.3	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.6	0.3	1.5	0
balance-sheet.row.total-current-assets	4037.13	929.1	1273.4	837	622.9	555.2	518.9	389.4	168.4	288.1	164.7	116.2	93.6	77.4	108.8	124.6	2.6	17	25.4	19.2	9.7	29.8	28.2	55	84.6	4.7
balance-sheet.row.property-plant-equipment-net	413.78	104.4	102.1	95.5	97.2	113.1	22.6	12.4	10	8.1	7.5	1.8	1.7	1.9	1.1	0	0	0	0	0	0	0.1	0.2	1.2	1.6	0.2
balance-sheet.row.goodwill	544.44	136.1	136.1	136.1	0	0	0	0	0	0	0	0	0	0	6.3	0	0	0	0	0	0	0	0	15.4	0	0
balance-sheet.row.intangible-assets	262.39	63.7	68.8	73.8	49.3	53.7	58.7	58.2	58.2	58.2	58.2	58.2	58.2	58.2	0	0	0	0	0	0	0	0	0	0	16.2	0
balance-sheet.row.goodwill-and-intangible-assets	806.83	199.8	204.9	209.9	49.3	53.7	58.7	58.2	58.2	58.2	58.2	58.2	58.2	58.2	6.3	0	0	0	0	0	0	0	0	15.4	16.2	0
balance-sheet.row.long-term-investments	16	6	0	50	0	0	0	0	0	0	0	0	0	2.1	2.2	2.1	0	0.3	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	-16	-6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	353.83	96.6	76.1	51	26.8	20.3	4.3	2	1.3	2.1	0.4	0.3	0.1	0.2	77.9	0	2.2	2.3	2.9	3.6	3.3	0	0	0	0.3	0.4
balance-sheet.row.total-non-current-assets	1574.44	400.8	383.1	406.5	173.3	187.1	85.6	72.6	69.5	68.4	66.2	60.3	60	62.4	87.5	2.1	2.2	2.5	2.9	3.7	3.3	0.1	0.2	16.6	18.1	0.6
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	5611.57	1329.8	1656.4	1243.5	796.2	742.3	604.6	462	238	356.6	230.9	176.5	153.6	139.8	196.3	126.7	4.8	19.5	28.3	22.9	13	29.8	28.3	71.6	102.7	5.3
balance-sheet.row.account-payables	243.14	65.4	50.5	35.8	42.9	13.2	17.7	14.7	10.4	7.5	9.2	5.9	7.1	2.3	1.4	0.3	1.3	0.9	7.2	1	2.6	0.7	0.9	4.4	3.4	0.7
balance-sheet.row.short-term-debt	35.17	10.6	8.1	10.1	12.6	12.3	0	0	0	3.1	0	3.3	3.1	0.1	0.1	0.2	1.6	1.3	0	0	0	0	2.3	5	0	0
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	4738.39	1193.4	1169.7	602.1	392.3	384.8	316.6	55.6	54.8	22	24.9	16.3	16.3	1.1	0.1	0	0.5	2.1	3.2	6.4	0	0	0	0	0	0
Deferred Revenue Non Current	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	722.76	215	131.7	89.2	63.4	0.3	62	30	17.6	0.7	10.4	7.2	5.6	2	1.3	1.7	1.5	1.3	2.5	3.9	2.4	2.3	0.4	0.7	0.7	0.1
balance-sheet.row.total-non-current-liabilities	5618.65	1436.1	1378.2	697.9	401.5	395.4	316.6	56.3	55.5	22.6	25	16.7	16.9	1.1	0.1	0	2.7	4.3	4.8	7.5	0.7	0.6	1	1.7	1.8	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	198.73	48.7	52.6	45.7	48.5	61.1	0	0	0	0	0	0.1	0.2	1.2	0.2	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	6433.24	1661.8	1568.5	833	520.3	480.6	396.3	101	83.5	44.9	44.6	33.2	32.7	5.6	3.4	2.8	7.6	8	14.5	12.3	5.8	3.6	4.9	11.9	5.9	0.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0.1
balance-sheet.row.common-stock	5.7	1.5	1.4	1.2	1	0.9	0.8	0.8	0.6	0.6	0.5	0.4	0.3	0.2	1.6	1.3	1.2	1.2	1	0.7	0.4	0.4	0.3	0.3	0.3	0
balance-sheet.row.retained-earnings	-12663.72	-3446.1	-2696.6	-2265.2	-1830.6	-1536.5	-1282.2	-957.9	-765.2	-589	-470.8	-391.6	-335.5	-294.2	-234.5	-228.1	-346.4	-330.8	-310.8	-254.7	-213.7	-186.5	-176.2	-139.8	-102.6	-22.8
balance-sheet.row.accumulated-other-comprehensive-income-loss	-2.99	-0.7	0.8	1	0.2	0	0	0	-0.1	-5.3	-3.3	-3.6	0	0.5	1	0.4	0	-0.2	-0.5	-0.5	-0.5	-0.5	-0.4	-1.2	0.2	-0.1
balance-sheet.row.other-total-stockholders-equity	11839.33	3113.5	2782.4	2673.6	2105.3	1797.3	1489.7	1318.2	919.2	905.3	659.8	538.1	456.1	427.7	423.9	350.2	342.4	341.3	324.2	265	221	212.8	199.7	200.3	198.9	27.2
balance-sheet.row.total-stockholders-equity	-821.68	-331.9	88	410.5	275.9	261.7	208.3	361.1	154.5	311.7	186.2	143.3	120.9	134.3	192.8	123.9	-2.8	11.5	13.9	10.5	7.2	26.2	23.4	59.7	96.8	4.5
balance-sheet.row.total-liabilities-and-stockholders-equity	5611.57	1329.8	1656.4	1243.5	796.2	742.3	604.6	462	238	356.6	230.9	176.5	153.6	139.8	196.3	126.7	4.8	19.5	28.3	22.9	13	29.8	28.3	71.6	102.7	5.3
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	-821.68	-331.9	88	410.5	275.9	261.7	208.3	361.1	154.5	311.7	186.2	143.3	120.9	134.3	192.8	123.9	-2.8	11.5	13.9	10.5	7.2	26.2	23.4	59.7	96.8	4.5
balance-sheet.row.total-liabilities-and-total-equity	5611.57	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	931.57	298.1	74.2	50	0	0	0	0	0	0	0	0	2.2	63.5	99.5	111.5	0.3	0.3	0	0	0	0	0	0	11.5	4.3
balance-sheet.row.total-debt	4773.56	1204	1177.9	612.3	404.8	397	316.6	55.6	54.8	25.1	24.9	19.7	19.4	1.2	0.2	0.2	2.1	3.4	3.2	6.4	0	0	0	0	0	0
balance-sheet.row.net-debt	2222.28	721.6	103.8	-104.5	-127.9	-90.4	-178.5	-325.6	-107.8	-257.7	-134.4	-94.2	-71.4	-13.6	-10.6	-12.5	0	-13.1	-21	-12.4	-9.2	-29.5	-27.3	-51.3	-71.6	-0.3

现金流量表

在 Insmed Incorporated 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.339 的转变。该公司最近通过发行 152.47 扩大了股本，与上一年相比出现了9.064 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 15.15. 公司的投资活动产生了现金使用净额，按报告货币计算达到-223604000.000. 与上一年相比， 5.466 发生了变化. 在同一时期，公司记录了 10.58, 0 和 -1.22，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将0 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 17.18，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000
cash-flows.row.net-income	-749.57	-749.6	-481.5	-434.7	-294.1	-254.3	-324.3	-192.6	-176.3	-118.2	-79.2	-56.1	-41.4	-59.7	-6.4	118.3	-15.7	-20	-56.1	-40.9	-27.2	-10.3	-36.4	-37.2	-79.9	-7.8
cash-flows.row.depreciation-and-amortization	10.58	10.6	10.3	14.2	14.2	10.2	4.8	2.9	2.4	2	1.1	0.7	0.6	0.3	0.1	0.7	1	0.4	3.4	12.9	0	0.1	0.3	1.5	0.8	0.1
cash-flows.row.deferred-income-tax	0	77	0	17.7	0	0	2.2	0	0	0	0	0	-0.8	0	0	0	0.5	-0.5	-0.9	0	0	0	-0.1	-0.1	0	0
cash-flows.row.stock-based-compensation	74.78	74.8	57.7	46	36.2	27	26.2	18.1	18	15.6	11.3	8.7	3	1.6	0.4	2.5	0.8	0.5	0.9	0	0	0	0.1	0.1	0	0
cash-flows.row.change-in-working-capital	-39.22	-39.2	6.6	-58.6	-3	-63	15.7	11.3	8.6	-0.6	1.8	-0.4	7.4	1.5	-1.7	-5.1	1.1	-6.3	4.6	0.2	2.2	-0.7	-3.5	4	2.1	0.2
cash-flows.row.account-receivables	-11.96	-12	-6.4	-8.1	2.7	-13.7	-5.5	0	0	0	0	0	0.8	-0.3	0	-0.1	0.1	0	-0.2	0	0	0	0	0	0	0
cash-flows.row.inventory	-13.61	-13.6	-1.7	-17.5	-21.2	-21.3	-7	0	0	0	0	0	0.5	1.7	-104.4	-1.8	0.2	0.6	-0.6	0	0	0	0	0	0	0
cash-flows.row.account-payables	17.44	15.2	50	-7.6	29.8	-5	3.9	3.6	2.8	-1.8	3.3	-1.1	4.7	0.9	-2.8	-1	0.4	-6.3	6.2	-1.7	2	-3.5	1.8	1.8	0	0
cash-flows.row.other-working-capital	-10.34	-28.8	-35.3	-25.4	-14.3	-23	24.4	7.7	5.9	1.2	-1.5	0.7	1.4	-0.7	105.5	-2.3	0.4	-0.5	-0.8	1.9	0.3	2.8	-5.4	2.2	2.1	0.2
cash-flows.row.other-non-cash-items	167.18	90.2	6.5	52	27.4	29.5	17.3	0.8	0.5	0.5	0.5	0.5	0.3	26	0	-127.5	0.1	0.6	6	0	0	0.1	15.5	-0.1	55.6	0.3
cash-flows.row.net-cash-provided-by-operating-activities	-536.25	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-13.29	-13.3	-9.9	-7.3	-6.8	-42.3	-14.8	-3	-4.2	-3.5	-5.4	-0.8	-0.3	-1	6.7	0	0	0	-5	0	0	0	-0.3	-0.3	-1.3	-0.1
cash-flows.row.acquisitions-net	-10	3.4	24.7	-6.7	0	0	0	0	0	0	0	0	0	0	-6.7	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-588.73	-588.7	-99.7	-50.3	0	0	0	0	0	0	0	0	-19.7	-1.2	-102.5	-108.7	0	-0.5	0	0	0	0	0	0	-19.2	-4.3
cash-flows.row.sales-maturities-of-investments	375	375	75	57	0	0	0	0	0	0	0	2.2	81.5	36.5	115.2	0	12.7	9.1	0	0	0	0	-0.2	11.5	12.3	0
cash-flows.row.other-investing-activites	-210.85	0	-24.7	-57	0	0	0	0	0	0	0	0	0	0	-6.7	127.5	0	0	0	0	0	0	11.7	0	3.6	0
cash-flows.row.net-cash-used-for-investing-activites	-223.6	-223.6	-34.6	-64.3	-6.8	-42.3	-14.8	-3	-4.2	-3.5	-5.3	1.3	61.5	34.4	6	18.7	12.7	8.6	-5	0	0	0	11.2	11.2	-4.6	-4.4
cash-flows.row.debt-repayment	-3.55	-1.2	-482.2	-225	-0.9	0	-57.8	0	0	0	-0.1	-0.1	-0.1	-0.1	-0.2	-1.2	-2.2	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	163.24	152.5	292.2	269.9	245.9	261.1	0	377.7	0	222.9	109	67	25.7	0	0	0.6	0.1	17.1	52.2	4.6	8.2	13	0.2	0.2	97.3	0.3
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	54.33	17.2	983.3	567.7	26.1	24.2	444.6	3.4	30.7	4.9	6.1	1.5	19.9	0	0	3.5	0	1	0.3	32.8	-3.6	0	0	0	0.1	0
cash-flows.row.net-cash-used-provided-by-financing-activities	168.44	168.4	793.3	612.5	271	285.3	386.7	381.1	30.7	227.8	115.1	68.4	45.4	-0.1	-0.2	2.9	-2.1	18.1	52.5	37.4	4.6	13	0.2	0.2	97.4	0.3
cash-flows.row.effect-of-forex-changes-on-cash	-0.25	-0.3	-1	-0.9	0.5	0	0	0.1	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	-11.2	0	0	0
cash-flows.row.net-change-in-cash	-591.66	-591.7	357.3	184	45.3	-7.6	113.9	218.6	-120.3	123.7	45.3	23.1	75.9	4.1	-2	10.6	-1.4	1.4	5.3	9.6	-20.3	2.2	-23.9	-20.4	71.3	-11.4
cash-flows.row.cash-at-end-of-period	2551.28	482.4	1074	716.8	532.8	487.4	495.1	381.2	162.6	282.9	159.2	113.9	90.8	14.8	10.7	12.7	2.1	3.6	24.1	18.8	9.2	29.5	27.3	51.3	71.6	0.3
cash-flows.row.cash-at-beginning-of-period	3142.94	1074	716.8	532.8	487.4	495.1	381.2	162.6	282.9	159.2	113.9	90.8	14.8	10.7	12.7	2.1	3.6	2.1	18.8	9.2	29.5	27.3	51.3	71.6	0.3	11.7
cash-flows.row.operating-cash-flow	-536.25	-536.2	-400.4	-363.3	-219.3	-250.6	-258	-159.6	-146.7	-100.7	-64.4	-46.7	-31	-30.2	-7.7	-11	-12	-25.3	-42.2	-27.8	-24.9	-10.8	-24.1	-31.8	-21.4	-7.2
cash-flows.row.capital-expenditure	-13.29	-13.3	-9.9	-7.3	-6.8	-42.3	-14.8	-3	-4.2	-3.5	-5.4	-0.8	-0.3	-1	6.7	0	0	0	-5	0	0	0	-0.3	-0.3	-1.3	-0.1
cash-flows.row.free-cash-flow	-549.53	-549.5	-410.3	-370.6	-226.2	-292.9	-272.8	-162.6	-150.9	-104.2	-69.8	-47.5	-31.3	-31.2	-1	-11	-12	-25.3	-47.2	-27.8	-24.9	-10.8	-24.3	-32	-22.7	-7.3

利润表行

Insmed Incorporated 的收入与上期相比变化了 0.244%。据报告, INSM 的毛利润为 239.63。该公司的营业费用为 920.56，与上年相比变化了 37.736%. 折旧和摊销费用为 10.58，与上一会计期间相比变化了 -0.469%. 营业费用报告为 920.56，显示37.736% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.484%. 营业收入为 -709.63，与上年相比变化了0.484%. 净利润的变化率为 0.557%。去年的净收入为-749.57.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000
income-statement-row.row.total-revenue	305.21	305.2	245.4	188.5	164.4	136.5	9.8	0	0	0	11.5	11.5	0	4.4	6.9	10.4	11.7	7.5	1	0.1	0.1	0.1	2	0.3	0.1	0.7
income-statement-row.row.cost-of-revenue	65.57	65.6	55.1	44.2	39.9	24.2	2.4	2.9	2.4	2	33.5	29.6	21.4	0	0	0	0	0.6	1.5	0	0	0	0	0	0	-0.1
income-statement-row.row.gross-profit	239.63	239.6	190.2	144.3	124.5	112.3	7.4	-2.9	-2.4	-2	-22	-18.1	-21.4	4.4	6.9	10.4	11.7	7	-0.5	0.1	0.1	0.1	2	0.3	0.1	0.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	571.01	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	344.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	3.23	1.9	5.1	5.1	5	5	0.6	0.3	0.1	0	0.1	0	0	12.2	10.3	9.8	5.1	8.5	32.8	5.7	4.2	3.6	18.4	0.1	0	2.5
income-statement-row.row.operating-expenses	920.56	920.6	668.4	512.1	389.8	347.5	314.8	188.9	173.4	117.5	87.4	66.5	42.4	40.1	15	19	26.1	27.4	53.9	27.6	27.6	10.7	36.4	40.5	31.2	8.9
income-statement-row.row.cost-and-expenses	986.14	986.1	723.5	556.2	429.6	371.7	317.2	188.9	173.4	117.5	87.4	66.5	42.4	40.1	15	19	26.1	28	55.4	27.6	27.6	10.7	36.4	40.5	31.2	8.8
income-statement-row.row.interest-income	1.88	1.9	11.1	0.2	1.7	9.9	0	0	0	0	0	0	0	0	1.8	0	0.5	1.2	1.9	0.8	0	0	0.6	0	0	0
income-statement-row.row.interest-expense	77.91	76.3	26.4	40.5	29.6	27.7	25.5	5.9	3.5	2.9	2.4	2.4	0.8	0	0.1	0.8	1.3	-0.7	-3.7	-14.2	0	0	0	0	0	0
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-4.39	15.6	-2	-68.7	-27.5	-18.3	8.7	1.9	0.7	0.2	0.2	0.1	1.8	-23.9	1.8	128.3	-0.5	0.5	-7.1	-13.5	-9	-0.1	-17.9	3	-50.4	0
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	3.23	1.9	5.1	5.1	5	5	0.6	0.3	0.1	0	0.1	0	0	12.2	10.3	9.8	5.1	8.5	32.8	5.7	4.2	3.6	18.4	0.1	0	2.5
income-statement-row.row.total-operating-expenses	-4.39	15.6	-2	-68.7	-27.5	-18.3	8.7	1.9	0.7	0.2	0.2	0.1	1.8	-23.9	1.8	128.3	-0.5	0.5	-7.1	-13.5	-9	-0.1	-17.9	3	-50.4	0
income-statement-row.row.interest-expense	77.91	76.3	26.4	40.5	29.6	27.7	25.5	5.9	3.5	2.9	2.4	2.4	0.8	0	0.1	0.8	1.3	-0.7	-3.7	-14.2	0	0	0	0	0	0
income-statement-row.row.depreciation-and-amortization	18.72	10.6	19.9	-5.6	5.4	4.5	1.2	2.9	2.4	2	1.1	0.7	0.6	0.3	0.1	0.7	1	0.4	3.4	12.9	0	0.1	0.3	1.5	0.8	0.1
income-statement-row.row.ebitda-caps	-664.03	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-719.13	-709.6	-478.1	-367.8	-265.2	-235.2	-307.3	-188.9	-173.4	-117.5	-87.4	-55	-42.4	-61.7	-8.1	-8.7	-14.4	-20.4	-54.4	-27.4	-27.4	-10.6	-37	-40.2	-81.5	-8.1
income-statement-row.row.income-before-tax	-747.01	-747	-480.2	-436.4	-292.7	-253.6	-324.1	-192.9	-176.2	-120.2	-89.6	-57.3	-41.4	-59.7	-6.4	118.8	-15.7	-20	-56.1	-40.9	-36.4	-10.3	-36.4	-37.2	-79.7	0
income-statement-row.row.income-tax-expense	2.56	2.6	1.4	-1.8	1.4	0.8	0.2	-0.3	0.1	-2	-10.4	-1.2	0.8	9.2	0.1	0.5	1.3	0	1.8	0	-9.2	-0.3	1.9	-74.3	0.2	-0.3
income-statement-row.row.net-income	-749.57	-749.6	-481.5	-434.7	-294.1	-254.3	-324.3	-192.6	-176.3	-118.2	-79.2	-56.1	-41.4	-59.7	-6.4	118.3	-15.7	-20	-56.1	-40.9	-27.2	-10.3	-36.4	-37.2	-79.9	-7.8